(Q46328728)

21 December 2017

title

Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease (English)

1 reference

21 December 2017

author name string

Paul E de Jong

series ordinal

1

1 reference

21 December 2017

Gerjan Navis

series ordinal

2

1 reference

21 December 2017

publication date

7 October 2008

1 reference

21 December 2017

Nature Clinical Practice Nephrology

published in

1 reference

21 December 2017

volume

4

1 reference

21 December 2017

issue

12

1 reference

21 December 2017

page(s)

654-655

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/ncpneph0963

exact match

0 references

cites work

Role of remission clinics in the longitudinal treatment of CKD.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0963

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0963

7 January 2021

Renoprotective therapy: titration against urinary protein excretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0963

7 January 2021

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0963

7 January 2021

Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0963

7 January 2021

Lipid abnormalities and cardiovascular risk in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0963

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0963

1 reference

21 December 2017

Dimensions Publication ID

1014849604

0 references

1 reference

21 December 2017